TGFB1 and cancer: Deregulation of TGFβ/BMP signaling pathways during the progression of various types of cancer, resulting from genetic and epigenetic changes in the genes of the components of TGFβ family signaling pathways or their repressors, leads to changes in the intensity and duration of signals and to consistent reorganization of the cell regulatory signaling network.